UPSTREAM BIO, INC. (UPB) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$42.32M*; Operating income -$42.37M; Depreciation and amortization $50.00K*.
- 2026-03-31: Basis Reported; EBITDA -$43.57M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$46.11M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$37.79M*; Operating income -$37.83M; Depreciation and amortization $46.00K*.
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$42.32M* | -$42.37M | $50.00K* | $773.00K | -5474.51%* | (m) | -$35.62M* | (m) | $36.09M | (m) | $0.00* |
|---|
| 2026-03-31 | Reported | -$43.57M | (m) | (m) | (m) | -4213.35% | (m) | -$47.85M | (m) | $36.56M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$46.11M | (m) | (m) | (m) | -6902.69% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$37.79M* | -$37.83M | $46.00K* | $683.00K | -5532.65%* | $64.00K* | -$22.24M* | (m) | $32.98M | (m) | $0.00* |
|---|
| 2025-06-30 | Reported | -$44.30M* | -$44.35M | $42.00K* | $937.00K | -4728.39%* | (m) | -$39.24M* | (m) | $37.87M | (m) | $0.00* |
|---|
| 2025-03-31 | Reported | -$31.97M | (m) | (m) | (m) | -5648.41% | (m) | -$41.16M | (m) | $25.80M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$26.27M | (m) | (m) | (m) | -4285.32% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$18.88M* | -$18.89M | $14.00K* | $607.00K | -3110.21%* | (m) | -$13.96M* | (m) | $15.43M | (m) | $0.00* |
|---|
| 2024-06-30 | Reported | -$17.53M* | -$17.54M | $13.00K* | $510.00K | -3436.67%* | (m) | -$8.04M* | (m) | $14.07M | (m) | $0.00* |
|---|
| 2024-03-31 | Reported | -$15M | (m) | (m) | (m) | -2343.75% | (m) | -$17.56M | (m) | $11.69M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$14.32M | (m) | (m) | (m) | -3181.33% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$9.39M | (m) | $621.00K | (m) | (m) | (m) | (m) | $7.79M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$160.17M | (m) | (m) | (m) | -5612.23% | $165.00K | -$133.28M | (m) | $136.81M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$77.68M | (m) | (m) | (m) | -3277.43% | $511.00K | -$59.17M | (m) | $62.97M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$40.05M | (m) | (m) | (m) | -1682.94% | $144.00K | -$37.93M | (m) | $31.80M | (m) | $0.00 |
|---|